Ana I Fernandes
Overview
Explore the profile of Ana I Fernandes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murdan S, Wei L, van Riet-Nales D, Gurmu A, Usifoh S, Taerel A, et al.
Explor Res Clin Soc Pharm
. 2023 Dec;
12:100378.
PMID: 38094713
Medicines can be taken by various routes of administration. These can impact the effects and perceptions of medicines. The literature about individuals' preferences for and perceptions of the different routes...
2.
Figueiredo S, Fernandes A, Carvalho F, Pinto J
Pharmaceutics
. 2023 Nov;
15(11).
PMID: 38004614
The successful integration of hot-melt extrusion (HME) and fused deposition modelling (FDM) depends on a better understanding of the impact of environmental conditions on the printability of formulations, since they...
3.
Fernandes A
Pharmaceutics
. 2023 Nov;
15(11).
PMID: 38004582
This Special Issue continues the previously published work [...].
4.
da Costa N, Azevedo R, Lopes J, Fernandes A, Pinto J
Pharmaceutics
. 2022 Dec;
14(12).
PMID: 36559080
In situ amorphization is a promising approach, considered in the present work, to enhance the solubility and dissolution rate of olanzapine, while minimizing the exposure of the amorphous material to...
5.
Fernandes A, Jozala A
Pharmaceutics
. 2022 Oct;
14(10).
PMID: 36297634
A drug's bioavailability, i.e., the extent to and rate at which it enters the systemic circulation, thus accessing the site of action, is largely determined by the properties of the...
6.
da Costa N, Daniels R, Fernandes A, Pinto J
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142179
The preparation of amorphous and co-amorphous systems (CAMs) effectively addresses the solubility and bioavailability issues of poorly water-soluble chemical entities. However, stress conditions imposed during common pharmaceutical processing (e.g., tableting)...
7.
da Costa N, Santos I, Fernandes A, Pinto J
J Pharm Sci
. 2022 Aug;
111(12):3327-3339.
PMID: 36007560
Co-amorphization is a promising approach to stabilize drugs in the amorphous form. Olanzapine, a poorly water-soluble drug was used in this study. Sulfonic acids (saccharin, cyclamic acid and acesulfame), free...
8.
da Costa N, Daniels R, Fernandes A, Pinto J
Pharmaceutics
. 2022 Jul;
14(8).
PMID: 35893791
The work evaluates the stability of amorphous and co-amorphous olanzapine (OLZ) in tablets manufactured by direct compression. The flowability and the compressibility of amorphous and co-amorphous OLZ with saccharin (SAC)...
9.
Figueiredo S, Fernandes A, Carvalho F, Pinto J
J Pharm Pharmacol
. 2021 Sep;
74(1):67-76.
PMID: 34591102
Objectives: The objective of this study was to develop a method for the preparation and characterization of paroxetine (PRX) tablets, obtained by coupling hot-melt extrusion and fused deposition modelling (FDM)-based...
10.
Auxtero M, Chalante S, Abade M, Jorge R, Fernandes A
Pharmaceutics
. 2021 Jan;
13(1).
PMID: 33478035
Late-life mild cognitive impairment and dementia represent a significant burden on healthcare systems and a unique challenge to medicine due to the currently limited treatment options. Plant phytochemicals have been...